HFS
CORT icon

HL Financial Services’s Corcept Therapeutics CORT Stock Holding History

HL Financial Services’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.63M Sell
224,189
-23
-0% -$286 0.04% 257
2018
Q4 		$3M Buy
224,212
+14,117
+7% +$187K 0.05% 225
2018
Q3 		$2.95M Buy
210,095
+31,872
+18% +$445K 0.05% 242
2018
Q2 		$2.8M Buy
+178,223
New +$3.1M 0.05% 235

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HL Financial Services's CORT Position: Q1 2019 in Review

HL Financial Services reduced its Corcept Therapeutics (CORT) stake by 0.01% in Q1 2019, selling an estimated $286 and leaving 224,189 shares worth $2.63M. The position accounts for 0.04% of the portfolio, ranked #257.

HL Financial Services first reported a position in CORT in Q2 2018 and has held it in 4 quarters since. The position peaked at $3M in Q4 2018. 208 funds tracked by Wall St. Rank hold CORT as of Q1 2019.

  • HL Financial Services held 224,189 shares of Corcept Therapeutics worth $2.63M as of Q1 2019.
  • HL Financial Services sold 23 Corcept Therapeutics shares in Q1 2019, an estimated $286.
  • Corcept Therapeutics made up 0.04% of HL Financial Services's portfolio in Q1 2019, its #257 holding.
  • HL Financial Services first reported a position in Corcept Therapeutics in Q2 2018 and has held it in 4 quarters since.
  • HL Financial Services's Corcept Therapeutics position peaked at $3M in Q4 2018.
  • 208 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2019.

Based on HL Financial Services's 13F filing for Q1 2019, filed 1 May 2019.